Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1998
09/24/1998WO1998041512A1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
09/24/1998WO1998041511A1 Pyridazinones as inhibitors of cyclooxygenase-2
09/24/1998WO1998041506A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
09/24/1998WO1998041236A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
09/24/1998WO1998041232A2 Compositions for modulating responsiveness to corticosteroids
09/24/1998WO1998041228A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
09/24/1998WO1998041226A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations
09/24/1998WO1998041221A1 Bifurcated method to process aloe whole leaf
09/24/1998WO1998041220A1 Mononuclear phagocytes and their use to promote axonal regeneration
09/24/1998WO1998041218A1 An aqueous metal bicarbonate solution and method of use
09/24/1998WO1998041214A1 Remedies for ischemic reflow disturbances
09/24/1998WO1998041201A1 Therapeutic compositions
09/24/1998WO1998041200A1 Therapeutic compositions
09/24/1998DE19711800A1 Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung Extension of the expression of transgenic proteins by modifying treatments
09/24/1998CA2284109A1 Secreted proteins and polynucleotides encoding them
09/24/1998CA2284108A1 Novel human cytokine/steroid receptor protein
09/24/1998CA2284062A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
09/24/1998CA2284035A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
09/24/1998CA2283961A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors
09/24/1998CA2283891A1 Mononuclear phagocytes and their use to promote axonal regeneration
09/24/1998CA2283797A1 Novel cannabinoid receptor agonists
09/24/1998CA2283438A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
09/24/1998CA2283100A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors
09/24/1998CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids
09/24/1998CA2254875A1 Pyrroloazepine compounds
09/23/1998EP0866128A2 Recombinant ricin toxin
09/23/1998EP0866125A1 Novel protein hmw human mp52
09/23/1998EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein
09/23/1998EP0865788A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent
09/23/1998EP0865491A1 Compounds having lectin properties and biological uses thereof
09/23/1998EP0865448A1 Apoptosis induced by monoclonal antibody anti-her2
09/23/1998EP0865446A1 Agents for promoting bone formation
09/23/1998EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
09/23/1998EP0865440A1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
09/23/1998EP0865439A1 Combinatorial libraries having aminodiol monomer subunits
09/23/1998EP0865430A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists
09/23/1998EP0865429A1 Azetidinone compounds for the treatment of atherosclerosis
09/23/1998EP0865427A1 Synthesis of 1alpha-hydroxy vitamin d
09/23/1998EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds
09/23/1998EP0865421A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors
09/23/1998EP0865298A1 Drug therapy
09/23/1998EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
09/23/1998EP0865280A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
09/23/1998EP0865275A2 Graft survival prolongation with porphyrins
09/23/1998EP0749481B1 Humanized monoclonal antibodies against human interleukin-4
09/23/1998EP0711280B1 Perhydroisoindole derivatives as p substance antagonists
09/23/1998EP0700383B1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
09/23/1998EP0627002B1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4
09/23/1998EP0539421B1 Novel oxazolyl derivatives
09/23/1998CN1194000A Methods for enhancement of protective immune responses
09/23/1998CN1193980A G-protein receptor HTNAD 29
09/23/1998CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
09/23/1998CN1193977A Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
09/23/1998CN1193968A 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
09/23/1998CN1193964A Benzo£g| quinoline derivatives
09/23/1998CN1193963A Aromatic compounds and pharmaceutical compositions containing them
09/23/1998CN1193961A Substituted benzylaminopiperidine compounds
09/23/1998CN1193912A Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral
09/23/1998CN1193911A Use of basic amino acids and derivatives for lowering ceramide levels
09/23/1998CN1193910A Use of alicyclic diamines as immunomodulators
09/23/1998CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
09/23/1998CN1193513A Use of pyrimidine derivatives for prevention of cancer, on their own or in combination with other therapeutic measures
09/23/1998CN1039909C Aminobenzoic acid derivatives
09/23/1998CN1039908C Tricyclic diazepine vasopressin antagonists
09/22/1998US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis
09/22/1998US5811553 Quinoline derivatives(2)
09/22/1998US5811549 Process of preparing imidazole compounds
09/22/1998US5811535 Human cartilege gp39-like gene
09/22/1998US5811534 Purine-based compounds for inclusion into oligonucleotides
09/22/1998US5811459 Pain relievers
09/22/1998US5811457 Therapeutical method for treating chronic arteriosclerosis obliterans
09/22/1998US5811456 Treatment of alzheimer's disease
09/22/1998US5811454 3-fluorobenzamides with nitrogen mustard groups; anticarcinogenic agents
09/22/1998US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders
09/22/1998US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid
09/22/1998US5811444 Compositions for reducing abnormal stimulation of endothelin receptors and novel compounds
09/22/1998US5811434 Methods and compositions for stimulating neurite growth
09/22/1998US5811431 Treating or preventing pain, inflammation, migraine, emesis, postherpetic neuralgia
09/22/1998US5811422 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
09/22/1998US5811405 Pharmaceuticals, diagnostic agents
09/22/1998US5811393 Heparin binding mitogen with homology to epidermal growth factor (EGF)
09/22/1998US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling
09/22/1998CA2138367C Use of phosphonates for the treatment of osteoporosis
09/22/1998CA2138366C Methods for the treatment of arthritis using phosphonates and nsaids
09/22/1998CA2131000C Indoles
09/22/1998CA2115279C Pharmaceutical products with a content of dexpanthenol for topical applications
09/22/1998CA2093797C Substituted imidazobenzazepines and imidazopyridoazepines
09/22/1998CA2054471C Aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside
09/22/1998CA1340055C Process for the preparation of tertiary carbinols containing an aminic substituent
09/21/1998CA2232787A1 Antiallergic agent having an anti-oxidant action
09/21/1998CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein
09/17/1998WO1998040508A1 Adenoviral vectors with modified tropism
09/17/1998WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies
09/17/1998WO1998040410A1 Polyvalent carbohydrate molecules
09/17/1998WO1998040386A1 Dioxino derivatives and their use as therapeutic agents
09/17/1998WO1998040385A1 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
09/17/1998WO1998040382A1 Novel tetrazoles
09/17/1998WO1998040381A1 Inhibitors of impdh enzyme
09/17/1998WO1998040370A1 Lta4 hydrolase inhibitors
09/17/1998WO1998040364A1 Lta4 hydrolase inhibitors
1 ... 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 ... 1564